LCT-Biochimie Pharmaceutique, Section des Sciences Pharmaceutiques, Université de Genève, Quai E. Ansermet 30, 1211 Genève, Switzerland.
ChemMedChem. 2011 Jul 4;6(7):1207-16. doi: 10.1002/cmdc.201100046. Epub 2011 May 17.
Protein kinase CK2 is an extremely well-conserved pleiotropic protein kinase with a growing list of substrates, the majority of which are proteins implicated in signal transduction, gene expression, and transcription-related functions. Protein kinase CK2 is a ubiquitous heterotetrameric serine/threonine protein kinase made up of two α or α' catalytic subunits and two β regulatory subunits. Moreover, protein kinase CK2 is defined as a "constitutively active" protein kinase in contrast to most other protein kinases characterized by the presence of distinct conformations associated with the active and inactive states. As previously demonstrated by in vitro mutation studies, CK2 activity is substantially regulated by the interaction between the N-terminal tail and the kinase domain. In fact, progressive deletions of the N-terminal tail show a decrease in the activity of the kinase. Even if the detrimental effects of Δ2-12 deletion can be partially reversed by the addition of a CK2β subunit, deletions Δ2-12 and Δ2-30 progressively decrease the basal activity of CK2. In particular, as experimentally demonstrated, the Δ2-12 N-terminal deletion affects both the K(M) value for ATP and for the substrate peptide, and the k(cat) value of CK2α. In this work, molecular dynamics (MD) simulations were carried out on wild-type (wt), Δ2-12 and Δ2-30 deletion mutants of CK2α in order to explore the role of the N-terminal tail on the conformational behavior of CK2. Furthermore, classical MD simulations were carried out to assess the anticipated impact of conformational changes in a novel set of CK2α mutant forms, such as the triple mutant Y206F-R10A-Y261F and the single mutant Y125F.
蛋白激酶 CK2 是一种高度保守的多功能蛋白激酶,其底物种类繁多,其中大多数是参与信号转导、基因表达和转录相关功能的蛋白质。蛋白激酶 CK2 是一种普遍存在的异四聚体丝氨酸/苏氨酸蛋白激酶,由两个α或α'催化亚基和两个β调节亚基组成。此外,蛋白激酶 CK2 被定义为一种“组成性激活”的蛋白激酶,与大多数其他蛋白激酶不同,后者的特征是存在与活性和非活性状态相关的独特构象。如先前的体外突变研究所示,CK2 活性受到 N 端尾部和激酶结构域之间相互作用的显著调节。事实上,N 端尾部的逐步缺失会导致激酶活性降低。即使通过添加 CK2β 亚基可以部分逆转 Δ2-12 缺失的不利影响,Δ2-12 和 Δ2-30 的缺失也会逐渐降低 CK2 的基础活性。特别是,如实验所示,Δ2-12 N 端缺失会影响 CK2α 对 ATP 和底物肽的 K(M)值以及 k(cat)值。在这项工作中,对 CK2α 的野生型(wt)、Δ2-12 和 Δ2-30 缺失突变体进行了分子动力学(MD)模拟,以探索 N 端尾部对 CK2 构象行为的作用。此外,进行了经典 MD 模拟,以评估构象变化对一组新的 CK2α 突变形式的预期影响,例如三突变体 Y206F-R10A-Y261F 和单突变体 Y125F。